Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
Authors
Keywords
Oncolytic viruses, Pancreatic cancer, OSM, Adenovirus, NDV
Journal
Molecular Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-16
DOI
10.1186/s12943-015-0479-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic Virus Immunotherapy for Melanoma
- (2015) Neal Dharmadhikari et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
- (2015) J Poutou et al. GENE THERAPY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-Associated Adipose Tissue Promotes Breast Cancer Progression by Paracrine Oncostatin M and Jak/STAT3 Signaling
- (2014) L. Lapeire et al. CANCER RESEARCH
- A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system
- (2014) Alejandro Aranda et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
- (2014) A. Mozaffarian et al. JOURNAL OF IMMUNOLOGY
- Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
- (2013) V. Heinemann et al. ANNALS OF ONCOLOGY
- Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers
- (2013) I-K Choi et al. CANCER GENE THERAPY
- Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes
- (2013) Esther Larrea et al. GUT
- Evolution of oncolytic viruses: novel strategies for cancer treatment
- (2013) Matthew J Atherton et al. Immunotherapy
- Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection
- (2013) Esther Larrea et al. JOURNAL OF HEPATOLOGY
- Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy
- (2013) Yinkai Xu et al. MELANOMA RESEARCH
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
- (2012) J. R. Tysome et al. CLINICAL CANCER RESEARCH
- Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
- (2012) Dmitriy Zamarin et al. Future Microbiology
- Evaluation of Monocytes as Carriers for Armed Oncolytic Adenoviruses in Murine and Syrian Hamster Models of Cancer
- (2012) Maria Bunuales et al. HUMAN GENE THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Significant Protection against High-Dose Simian Immunodeficiency Virus Challenge Conferred by a New Prime-Boost Vaccine Regimen
- (2011) J. B. Schell et al. JOURNAL OF VIROLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Oncostatin M Renders Epithelial Cell Adhesion Molecule–Positive Liver Cancer Stem Cells Sensitive to 5-Fluorouracil by Inducing Hepatocytic Differentiation
- (2010) Taro Yamashita et al. CANCER RESEARCH
- OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
- (2010) Howard L Kaufman et al. Future Oncology
- gp130 at the nexus of inflammation, autoimmunity, and cancer
- (2010) J. S. Silver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Intensive Pharmacological Immunosuppression Allows for Repetitive Liver Gene Transfer With Recombinant Adenovirus in Nonhuman Primates
- (2010) Antonio Fontanellas et al. MOLECULAR THERAPY
- Oncolytic viruses from the perspective of the immune system
- (2009) Ramon Alemany et al. Future Microbiology
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial Cells
- (2009) E. Larrea et al. JOURNAL OF VIROLOGY
- Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
- (2009) Sergia Bortolanza et al. MOLECULAR THERAPY
- Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model
- (2008) K. Toth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started